Sangamo Biosciences reported $-43173000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Alnylam Pharmaceuticals ALNY:US $ -277.4M 37.06M
Amgen AMGN:US $ 1317M 159M
Avrobio Inc AVRO:US $ -28054000 1.78M
Bayer BAYN:GR € -298M 3589M
Biocryst Pharmaceuticals BCRX:US $ -58.86M 15.34M
Biogen BIIB:US $ 1058M 754.2M
Biomarin Pharmaceutical BMRN:US $ 27.66M 93.13M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 83800M 96400M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
IONIS PHARMACEUT IONS:US $ -105.14M 39.97M
Johnson & Johnson JNJ:US $ 4814M 335M
Karyopharm Therapeutics KPTI:US $ -49062000 7.66M
Merk MRK:US $ 3944M 366M
Novartis NOVN:VX SF 1694M 528M
Omeros OMER:US $ -30849000 2.16M
Pfizer PFE:US $ 9905M 2042M
Regulus Therapeutics RGLS:US $ -7.26M 0.54M
Sangamo Biosciences SGMO:US $ -43.17M 0.8M
Sarepta Therapeutics SRPT:US $ -231.48M 126.46M
Ultragenyx Pharmaceutical RARE:US $ -158.16M 5.84M
Vertex Pharmaceuticals VRTX:US $ 810.5M 48.4M
Ziopharm Oncology ZIOP:US $ -9.93M 0.14M